These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 3481271)
21. Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay. Langlois AJ; Matthews TJ; Weinhold KJ; Chaffee S; Hershfield M; Bolognesi DP AIDS Res Hum Retroviruses; 1988 Feb; 4(1):63-9. PubMed ID: 3163254 [TBL] [Abstract][Full Text] [Related]
22. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Arthur LO; Pyle SW; Nara PL; Bess JW; Gonda MA; Kelliher JC; Gilden RV; Robey WG; Bolognesi DP; Gallo RC Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8583-7. PubMed ID: 3479807 [TBL] [Abstract][Full Text] [Related]
23. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. Albert J; Bredberg U; Chiodi F; Böttiger B; Fenyö EM; Norrby E; Biberfeld G AIDS Res Hum Retroviruses; 1987; 3(1):3-10. PubMed ID: 3040053 [TBL] [Abstract][Full Text] [Related]
24. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection. Nara P; Smit L; Dunlop N; Hatch W; Merges M; Waters D; Kelliher J; Krone W; Goudsmit J Dev Biol Stand; 1990; 72():315-41. PubMed ID: 2282990 [TBL] [Abstract][Full Text] [Related]
25. Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell lines. Warren JT; McMahon JB; Weislow OS; Gulakowski RJ; Kiser RF; Boyd MR AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1131-7. PubMed ID: 2265028 [TBL] [Abstract][Full Text] [Related]
27. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461 [TBL] [Abstract][Full Text] [Related]
28. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. Robinson WE; Montefiori DC; Mitchell WM Biochem Biophys Res Commun; 1987 Dec; 149(2):693-9. PubMed ID: 3426595 [TBL] [Abstract][Full Text] [Related]
29. Persistent coinfection of T lymphocytes with HTLV-II and HIV and the role of syncytium formation in HIV-induced cytopathic effect. Montefiori DC; Mitchell WM Virology; 1987 Oct; 160(2):372-8. PubMed ID: 2821680 [TBL] [Abstract][Full Text] [Related]
30. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Nagy K; Clapham P; Cheingsong-Popov R; Weiss RA Int J Cancer; 1983 Sep; 32(3):321-8. PubMed ID: 6604033 [TBL] [Abstract][Full Text] [Related]
31. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens. Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356 [TBL] [Abstract][Full Text] [Related]
32. Induction of syncytia by the bovine C-type leukemia virus. Diglio CA; Ferrer JF Cancer Res; 1976 Mar; 36(3):1056-67. PubMed ID: 175949 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of AIDS virus replication by acemannan in vitro. Kahlon JB; Kemp MC; Carpenter RH; McAnalley BH; McDaniel HR; Shannon WM Mol Biother; 1991 Sep; 3(3):127-35. PubMed ID: 1768365 [TBL] [Abstract][Full Text] [Related]
34. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Chackerian B; Haigwood NL; Overbaugh J Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Cummins LM; Weinhold KJ; Matthews TJ; Langlois AJ; Perno CF; Condie RM; Allain JP Blood; 1991 Mar; 77(5):1111-7. PubMed ID: 1995097 [TBL] [Abstract][Full Text] [Related]
37. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567 [TBL] [Abstract][Full Text] [Related]
38. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4. Watkins BA; Crowley R; Davis AE; Louie AT; Reitz MS J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472 [TBL] [Abstract][Full Text] [Related]
39. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282 [TBL] [Abstract][Full Text] [Related]
40. Replication of human immunodeficiency virus in two T-cell lines and their application as antigens for immunofluorescence. Kawatani T; Hattori N; Kurimura T Microbiol Immunol; 1988; 32(5):491-8. PubMed ID: 3050377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]